5242.0: Wednesday, November 15, 2000 - Board 1

Abstract #18417

Iodine-131 Case Study on Environmental Medicine: A Training Tool for Health Care Providers to Evaluate the Public Health Implications of Exposure to I-131

Jessica Cafarella, American College of Preventive Medicine, 1660 L Street NW, Suite 206, Washington, DC, DC 20036-5603, 202-466-2044, jdc@acpm.org

Testing of nuclear weapons during the 1950s resulted in widespread exposure of the U.S. population at that time (~160 million people) to a potentially hazardous radioactive substance: Iodine-131 (I-131). Since then, exposure to I-131 has been linked with the occurrence of thyroid disorders and thyroid cancer. Residents of some geographical areas experienced higher cumulative average doses of I-131 than others, and areas downwind from nuclear test sites especially were affected. Ingestion of the milk from cows and goats who grazed in nearby contaminated pastures was a primary route of human exposure to I-131.

The Agency for Toxic Substances and Disease Registry, the American College of Medical Toxicologists, and the American College of Preventive Medicine are developing a case study in environmental medicine on I-131 as a training tool for health professionals to explore the clinical evaluation, diagnosis, treatment, and management of exposure to I-131. This case study is intended to educate health professions about the impact of I-131 and to help providers detect and accurately diagnose the acute and latent effects of exposure to such radiation. The case study examines the impact of I-131 on children as the most susceptible age group, due to their smaller body size and increased milk consumption. Health risk communication and methods for patients and health professions to cope with the physical and psychological effects of exposure to nuclear contamination also are discussed.

Learning Objectives: N/A

Keywords: Training, Providers

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 128th Annual Meeting of APHA